<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac adverse effects are not commonly reported complications of nebulized <z:chebi fb="2" ids="28918">epinephrine</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>We present a case of critical <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> developed at the Pediatric Emergency Department in an otherwise healthy infant after receiving 3 mg of L-<z:chebi fb="2" ids="28918">epinephrine</z:chebi> (1:1000) nebulization over a 90 min period for a diagnosis of <z:hpo ids='HP_0011950'>bronchiolitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Unstable <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> was found after the nebulization therapy that required chemical cardioversion </plain></SENT>
<SENT sid="3" pm="."><plain>Frequent <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo> (<z:mp ids='MP_0010018'>PVCs</z:mp>) were found initially following the cardiac insult that was controlled with oral <z:chebi fb="0" ids="2663">amiodarone</z:chebi>, and disappeared during follow-up </plain></SENT>
<SENT sid="4" pm="."><plain>Although <z:chebi fb="2" ids="28918">epinephrine</z:chebi> inhalation is generally safe, adverse life-threatening events could be unpredictable and may evolve even after a single dose of nebulized <z:chebi fb="2" ids="28918">epinephrine</z:chebi> </plain></SENT>
</text></document>